AMGN
<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
Last Updated: Jul 01, 2026 03:20:01 PM (GMT)
AMGN: The current market price is 361.29, reflecting a slight decrease of -0.21%.
Support and Resistance Levels The pivot point is at 362.04. The support levels are 362.04, 362.04, and 362.04, while the resistance levels are also 362.04, 362.04, and 362.04.
Indicators The RSI is at 66.68, indicating overbought conditions, but it has fallen from higher levels. The ATR is 0.30829, and the MACD shows a bearish divergence with MACD at 0.54661 and signal at 0.67289. The Parabolic SAR is at 358.51467, indicating a potential bullish trend if crossed upward.
Market Sentiment The market is bearish as the price is below the pivot point (362.04) with conflicting indicator signals.
AMGN Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (amgn) Amgen Inc.
Company Background
Amgen Inc. (NASDAQ: AMGN), founded in 1980, is one of the world’s largest biotechnology companies, dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Based in Thousand Oaks, California, Amgen focuses primarily on the treatment of serious illnesses in areas such as oncology, nephrology, and inflammation. With a commitment to scientific excellence, the company leverages its proprietary research and advanced technologies to create groundbreaking therapies that improve patient outcomes.
Market Position
Amgen holds a prominent position in the global biopharmaceutical industry, being recognized for its robust portfolio of products, including blockbuster medications like Enbrel, Neulasta, and Prolia. The company’s innovative approach, combined with its strong emphasis on research and development, has enabled it to maintain a competitive edge within the biotechnology sector. As of 2023, Amgen continues to progress through a pipeline rich with potential treatments that address unmet medical needs, further solidifying its status as a leader in the industry.
Key Financial Highlights
In its most recent fiscal year, Amgen reported impressive financial performance, with revenues exceeding $26 billion and a net income of $7 billion. The company has consistently demonstrated strong operating cash flow, allowing for strategic investments in research and development along with shareholder returns through dividends and stock buybacks. Furthermore, Amgen’s commitment to operational efficiency has resulted in a favorable gross margin, reinforcing its financial stability in a competitive marketplace.
Industry Highlights
The biotechnology industry is poised for significant growth, driven by advancements in personalized medicine and increasing demand for novel therapies. Amgen is well-positioned to capitalize on this growth, with a strong emphasis on innovation and a robust pipeline of therapies currently in various stages of development. The company’s strategic collaborations and partnerships within the healthcare ecosystem further enhance its ability to deliver cutting-edge solutions to patients worldwide.
How to Buy or Trade Amgen Inc. Stock (AMGN) with AvaTrade
Trading or investing in Amgen Inc. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol AMGN, which represents Amgen Inc.. Before placing a trade, review the live Amgen Inc. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell Amgen Inc. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Amgen Inc. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
Ava
